Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice

BMC Neuroscience

Volumn 7, Issue , 2006, Pages

  Bigini, Paolo ^a   Gardoni, Fabrizio ^b   Barbera, Sara ^a   Cagnotto, Alfredo ^a   Fumagalli, Elena ^b   Longhi, Annalisa ^b   Corsi, Massimiliano M ^b   Di Luca, Monica ^b   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; RECEPTOR SUBUNIT;

AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CERVICAL SPINAL CORD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GLIOSIS; LIVER HOMOGENATE; LUMBAR SPINE; MOTOR NEURON DISEASE; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NERVE TRACT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; MICE; MOTOR NEURON DISEASE; PROTEIN SUBUNITS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 33751095362     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-7-71     Document Type: Article

References (26)

1. Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124 Suppl:96-107.
2. Rowland LP: Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1998, 160 Suppl 1:S6-24.
3. Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, Schoenfeld DA, Hosler BA, Horvitz HR, Brown RH: Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997, 41:210-221.
4. Mennini T, Bendotti C: Excitotoxicity in amyotrophic lateral sclerosis: selective vulnerability of motor neurons. In Excitotoxicity in neurological diseases New Therapeutic Challenge Edited by: Ferrarese C and Beal MF., Kluwer Academic Publishers; 2004:217-228.
5. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW: Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci U S A 1993, 90:6591-6595.
6. Raman IM, Zhang S, Trussell LO: Pathway-specific variants of AMPA receptors and their contribution to neuronal signaling. J Neurosci 1994, 14:4998-5010.
7. Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, Jeong SY, Kanazawa I: Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. J Neurochem 2003, 85:680-689.
8. Takuma H, Kwak S, Yoshizawa T, Kanazawa I: Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol 1999, 46:806-815.
9. Kuner R, Groom AJ, Muller G, Kornau HC, Stefovska V, Bresink I, Hartmann B, Tschauner K, Waibel S, Ludolph AC, Ikonomidou C, Seeburg PH, Turski L: Mechanisms of disease: motoneuron disease aggravated by transgenic expression of a functionally modified AMPA receptor subunit. Ann N Y Acad Sci 2005, 1053:269-286.
10. Falconer DS: Wobbler mouse. News Letters 1956, 15:23.
11. Schmitt-John T, Drepper C, Mussmann A, Hahn P, Kuhlmann M, Thiel C, Hafner M, Lengeling A, Heimann P, Jones JH, Meisler MH, Jockusch H: Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat Genet 2005, 37:1213-1215.
12. Mitsumoto H, Ikeda K, Holmlund T, Greene T, Cedarbaum JM, Wong V, Lindsay RM: The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann Neurol 1994, 36:142-148.
13. Tsuzaka K, Ishiyama T, Pioro EP, Mitsumoto H: Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease. Muscle Nerve 2001, 24:474-480.
14. Krieger C, Perry TL, Hansen S, Mitsumoto H, Honore T: Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse). Can J Neurol Sci 1992, 19:462-465.
15. Gonzalez Deniselle MC, Gonzalez SL, Lima AE, Wilkin G, De Nicola AF: The 21-aminosterold U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis. Neurochem Res 1999, 24:1-8.
16. Blondet B, Barlovatz-Meimon G, Festoff BW, Soria C, Soria J, Rieger F, Hantai D: Plasminogen activators in the neuromuscular system of the wobbler mutant mouse. Brain Res 1992, 580:303-310.
17. Bigini P, Bastone A, Mennini T: Glutamate transporters in the spinal cord of the wobbler mouse. Neuroreport 2001, 12:1815-1820.
18. Krieger C, Wagey R, Shaw C: Amyotrophic lateral sclerosis: quantitative autoradiography of [3H]MK-801/NMDA binding sites in spinal cord. Neurosci Lett 1993, 159:191-194.
19. Tomiyama M, Kannari K, Nunomura J, Oyama Y, Takebe K, Matsunaga M: Quantitative autoradiographic distribution of glutamate receptors in the cervical segment of the spinal cord of the wobbler mouse. Brain Res 1994, 650:353-357.
20. Gardoni F, Schrama LH, Kamal A, Gispen WH, Cattabeni F, Di Luca M: Hippocampal synaptic plasticity involves competition between Ca2+/ calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor. J Neurosci 2001, 21:1501-1509.
21. Finardi A, Gardoni F, Bassanini S, Lasio G, Cossu M, Tassi L, Caccia C, Taroni F, LoRusso G, Di Luca M, Battaglia G: NMDA receptor composition differs among anatomically diverse malformations of cortical development. J Neuropathol Exp Neurol 2006, 65:883-893.
22. Hantaz-Ambroise D, Cambier D, Ait-Ikhlef A, Parvy P, Murawsky M, Rieger F: Excess extracellular and low intracellular glutamate in poorly differentiating wobbler astrocytes and astrocyte recovery in glutamine-depleted culture medium. J Neurochem 1995, 65:1199-1204.
23. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, Fracasso C, Guiso G, Elger B, Schneider H, Seilheimer B, Caccia S, Bendotti C: Glutamate AMPA receptors change in motor neurons of SODIG93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 2006, 83:134-146.
24. Canton T, Bohme GA, Boireau A, Bordier F, Mignani S, Jimonet P, Jahn G, Alavijeh M, Stygall J, Roberts S, Brealey C, Vuilhorgne M, Debono MW, Le Guern S, Laville M, Briet D, Roux M, Stutzmann JM, Pratt J: RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. J Pharmacol Exp Ther 2001, 299:314-322.
25. Fumagalli E, Bigini P, Barbera S, De Paola M, Mennini T: Riluzole, unlike the AMPA antagonist RPRI 19990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease. Exp Neurol 2006, 198:114-128.
26. Kozachuk WE, Mitsumoto H, Salanga VD, Beck GJ, Wilber JF: Thyrotropin-releasing hormone (TRH) in murine motor neuron disease (the wobbler mouse). J Neurol Sci 1987, 78:253-260.